Compare NiSource Inc Common Stock (NI) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NiSource Inc Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? NiSource Inc Common Stock trades at $40.58 (market cap $19.44B), while Nuvation Bio Inc. Class A Common Stock trades at $4.96 (market cap $1.74B). The key difference: NiSource Inc Common Stock is far larger — about 11.2× Nuvation Bio Inc. Class A Common Stock's market cap, and NiSource Inc Common Stock pays a 2.96% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NiSource Inc Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| NI | NUVB | |
|---|---|---|
Market Cap | $19.44B | $1.74B |
Volume | 3,945,959 | 9,289,619 |
Sector | Utilities | Health |
52-Week High | $49.08 | $9.54 |
52-Week Low | $39.00 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $36.77B | $1.33B |
Dividend Yield | 2.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NiSource Inc Common Stock
NiSource is an energy holding company whose regulated subsidiaries provide natural gas and electricity services. Its business is organized around gas distribution and electric operations in the United States.
Read more on NI →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
